|
Indobufen Impurity
|
2-（3-硝基苯基）-丁酸
|
21762-22-1
|
|
2,3,5-trimethyl-6-nitro-1-oxidopyridin-1-ium
|
2,3,5-三甲基-6-硝基吡啶氮氧化物
|
|
|
1-(2-methyl-5-nitro-imidazol-1-yl)propan-2-one
|
奧硝唑雜質(zhì)2
|
31876-69-4
|
|
((S)-2-AMINO-4-METHYLSULFANYL-BUTYRIC ACID
|
L-蛋氨酸叔丁酯
|
4976-72-1
|
|
Ademetionine-1，4-Butanedisulfonate Impurity 5
|
丁二磺酸腺苷蛋氨酸雜質(zhì)
|
4239-21-8
|
|
Isopropyl myristate
|
肉豆蔻酸異丙酯
|
110-27-0
|
|
Moxidectin
|
莫昔克丁
|
113507-06-5
|
|
Palbociclib Impurity
|
哌柏西利雜質(zhì)51
|
571189-65-6
|
|
Emtricitabine Enantiomer
|
恩曲他濱雜質(zhì)
|
137530-41-7
|
|
Emtricitabine Impurity
|
恩曲他濱雜質(zhì)
|
145986-11-4
|
|
Ivermectin
|
伊維菌素
|
70288-86-7
|
|
(2S)-2-Aminobutanedioic acid ditert-butyl ester
|
(S)-2-氨基琥珀酸二叔丁酯
|
13795-73-8
|
|
L-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-, 1,1-dimethylethyl ester
|
N6-(叔丁氧羰基)-L-賴氨酸叔丁基酯
|
14529-23-8
|
|
diethyl butane-1,4-disulfonate
|
二乙基丁烷-1,4-二磺酸鹽
|
98544-67-3
|
|
(Z)-11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepine-2-carbaldehyde 2,2,2-trifluoroacetate
|
鹽酸奧洛他定甲醛
|
2519517-77-0
|
|
IIvabradine R-Isomer HCl
|
鹽酸伊伐布雷定雜質(zhì)
|
148849-68-7
|
|
GE, IN RE, R, SC standard solution 1
|
Ge,In Re, R,Sc標(biāo)準(zhǔn)溶液 1
|
|
|
1,6-NAPHTHYRIDINE-3-CARBOXAMIDE, 4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-1,4-DIHYDRO-2,8-DIMETHYL-, (4R)-
|
非奈利酮對(duì)映體雜質(zhì)
|
1050477-30-9
|
|
Selexipag Impurity
|
N-(4-((5,6-二苯基吡嗪-2-基)氧基)丁基)-N-異丙基-5，6-二苯基吡唑嗪-2-胺
|
|
|
Mometasone Furoate EP Impurity T
|
糠酸莫米松EP雜質(zhì)T
|
|
|
Daunorubicin EP Impurity E
|
柔紅霉素EP雜質(zhì)E
|
28008-51-7
|
|
Daunorubicin EP Impurity E
|
柔紅霉素EP雜質(zhì)E
|
125515-17-5
|
|
Linagliptin Impurity 18
|
利格列汀甲胺物
|
2468656-63-3
|
|
Linagliptin Impurity 10
|
利格列汀脫哌啶物
|
1911621-52-7
|
|
Midazolam EP Impurity H
|
咪達(dá)唑侖EP雜質(zhì)H
|
119401-13-7
|
|
Midazolam EP Impurity B
|
咪達(dá)唑侖EP雜質(zhì)B
|
59469-74-8
|
|
2-Isopropyl-5-methyl-2-hexenal
|
可可醛
|
35158-25-9
|
|
2-[4-(1-METHYLPROPYL)PHENYL]PROPANOIC ACID
|
布洛芬雜質(zhì)O
|
64451-76-9
|
|
Doxofylline Impurity 3
|
多索茶堿雜質(zhì)3
|
1174289-18-9
|
|
Doxofylline Impurity 2
|
多索茶堿雜質(zhì)2
|
5614-53-9
|
|
(R)-3-(Boc-Amino)piperidine
|
(R)-3-叔丁氧羰基氨基哌啶
|
309956-78-3
|
|
Mometasone Furoate EP Impurity A
|
糠酸莫米松EP雜質(zhì)A
|
83880-65-3
|
|
2-(1-chloroethyl)pyridine
|
2-(1-氯乙基)吡啶
|
10445-92-8
|
|
2-(2-Chloroethyl)pyridine
|
2-(2-氯乙基)吡啶
|
16927-00-7
|
|
Cefuroxime Sodium EP Impurity B
|
頭孢呋辛鈉EP雜質(zhì)B
|
39685-31-9
|
|
Cefuroxime Sodium EP Impurity C
|
頭孢呋辛鈉EP雜質(zhì)C
|
69822-88-4
|
|
Cefuroxime Sodium EP Impurity G
|
頭孢呋辛鈉EP雜質(zhì)G
|
97232-98-9
|
|
Avanafil Impurity 46
|
阿伐那非雜質(zhì)46
|
372117-53-8
|
|
Febuxostat Impurity z2-9
|
非布司他雜質(zhì)z2-9
|
|
|
Cefuroxime Sodium EP Impurity I
|
頭孢呋辛鈉EP雜質(zhì)I
|
97148-39-5
|
|
Omeprazole Impurity 34
|
奧美拉唑硫醚N吡啶取代物
|
1346600-29-0
|
|
Domperidone EP Impurity B
|
多潘立酮雜質(zhì)B
|
1346598-11-5
|
|
Domperidone EP Impurity C
|
多潘立酮雜質(zhì)C
|
118435-03-3
|
|
6-Hydroxy chlorzoxazone
|
6-羥基氯唑沙宗
|
1750-45-4
|
|
Luliconazole Impurity D
|
盧立康唑雜質(zhì)D
|
101529-76-4
|
|
HA1405-013126
|
|
1202707-22-9
|
|
HA1405-013121
|
|
913555-67-6
|
|
2-[[( 3,5-DIMETHYL-4-( 2,2,2-TRIFLUOROETHOXY) PYRIDINYL)METHYL]THIO] -1H-BENZIMIDAZOL
|
2-[[(3,5-二甲基-4-(2,2,2-三氟乙氧基)吡啶基)甲基]硫代]-1H-苯并咪唑
|
103602-42-2
|
|
[(3s, 4R) -3-ethyl-4-(3h-imidazole [1,2-a ]1H-pyrrole [2,3-e ] pyrazine-8-yl) pyrrolidine-1-yl ](1h-imidazole-1-yl) methyl ketone
|
烏帕替尼雜質(zhì)9
|
|
|
(3s, 4R) -3-ethyl-4-(6ethyl-6h-imidazole [1,2-a ]1H-pyrrole [2,3-e ] pyrazine-8-yl)-n-(2,2,2-trifluoroethyl) pyrrolidine-1-formamide
|
烏帕替尼15
|
|
|
Tropisetron Hydrochloride Impurity V
|
鹽酸托烷司瓊雜質(zhì)V
|
|
|
Afatinib Impurity 24
|
阿法替尼雜質(zhì)24
|
|
|
Lenvatinib Impurity CDP-082-IMP AC
|
侖伐替尼雜質(zhì)CDP-082-imp AC
|
|
|
Lenvatinib Impurity CDP-082-IMP AB
|
侖伐替尼雜質(zhì)CDP-082-imp AB
|
|
|
Dimethyl thiosine
|
二甲硫腺苷
|
|
|
3-Ethyl-6,7,8,9-tetrahydro-9-hydroxy-2-Methyl-4H-pyrido[1,2-a]pyriMidin-4-one
|
帕利哌酮雜質(zhì)54
|
849903-79-3
|
|
Lenvatinib Impurity CDP-082-IMP X
|
侖伐替尼雜質(zhì)CDP-082-imp X
|
|
|
Upadacitinib Impurity D
|
烏帕替尼雜質(zhì)D
|
2095311-51-4
|
|
L-Pyroglutamic acid
|
L-焦谷氨酸
|
98-79-3
|
|
(S)-4-((3-chloro-4-methoxybenzyl)amino)-N-ethyl-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxamide
|
(S) -4-((3-氯-4-甲氧基芐基)氨基)-N-乙基-2-(2-(羥甲基)吡咯烷-1-基)嘧啶-5-甲酰胺
|
2520114-39-8
|
|
Avanafil Impurity 48
|
阿伐那非雜質(zhì)48
|
1830294-64-8
|
|
METHYL DODECYLBENZENE SULFONATE
|
十二烷基苯磺酸甲酯
|
52319-06-9
|
|
Vitamin B6 Impurity 6
|
VB6雜質(zhì)6
|
1385767-86-1
|
|
Apixaban Impurity C
|
阿哌沙班雜質(zhì)C
|
2098457-92-0
|
|
Benzenesulfonic Acid Monohydrate
|
苯磺酸一水合物
|
26158-00-9
|
|
1-Butanesulfonic acid, 4-hydroxy-, methyl ester
|
4-羥基丁烷-1-磺酸甲酯
|
343928-18-7
|
|
Melphalan Impurity J
|
鹽酸美法侖雜質(zhì)J
|
|
|
Granisetron Impurity 4
|
格拉司瓊雜質(zhì)4
|
160177-67-3
|
|
2-AMINO-3,4-DIFLUOROBENZALDEHYDE
|
2-氨基-3,4-二氟苯甲醛
|
1602097-79-9
|
|
Olmesartan Impurity D
|
奧美沙坦酯雜質(zhì)D
|
144690-92-6
|
|
N-nitrososarcosine ethyl ester
|
N-亞硝基肌氨酸乙酯
|
13344-50-8
|
|
(NitrosoiMino)bisacetic Acid Diethyl Ester
|
(亞硝基亞氨基)雙乙酸二乙酯
|
5438-83-5
|
|
7-Ketocholesterol
|
7-酮基膽固醇
|
566-28-9
|
|
Avanafil Impurity
|
(S) -4-((3-氯-4-甲氧基芐基)氨基)-2-(2-(羥甲基)吡咯烷-1-基)-N-異丙基嘧啶-5-甲酰胺
|
2520114-11-6
|
|
(R)-7-(benzyloxy)- 3,4,12,12a-tetrahydro- 1H-[1,4]oxazino[3,4- c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione
|
（R）-7-芐氧基-3,4,12,12a-四氫-1H-[1,4]噁嗪并[3,4-c]吡啶并[2,1-f][1,2,4]三嗪-6,8-二酮
|
1985607-70-2
|
|
Granisetron EP Impurity E
|
格拉司瓊雜質(zhì)E
|
76272-56-5
|
|
4'-Methylacetophenone
|
對(duì)甲基苯乙酮
|
122-00-9
|
|
(3R, 4R) -3-ethyl-4-(3h-imidazole [1,2-a ]1H-pyrrole [2,3-e ] pyrazine-8-yl)-n-(2,2,2-trifluoroethyl) pyrrolidine-1-formamide
|
烏帕替尼雜質(zhì)26
|
1310726-59-0
|
|
P-(METHYLTHIO)PHENYLACETONITRILE
|
4-?(甲硫基)苯乙腈
|
38746-92-8
|
|
1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone
|
1-?(6-甲基-3-吡啶基)?-2-?[?4-?(甲硫基)苯基]乙酮
|
221615-72-1
|
|
(R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one
|
磷酸特地唑胺氯代物
|
1239662-46-4
|
|
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro-
|
布南色林雜質(zhì)F
|
1648791-23-4
|
|
4-Hexenoic acid, 3-(aminomethyl)-5-methyl-
|
(R)-4,5-脫氫普瑞巴林
|
216576-74-8
|
|
NA
|
2,2'-（1H，1'H-[3,3'-聯(lián)吲唑]-6,6'-二?；p（磺胺基）雙（N-甲基苯甲酰胺）
|
|
|
PCI-7517(RRT0.51) Ibrutinib Impurity
|
PCI-7517（RRT0.51） 伊布替尼雜質(zhì)
|
|
|
Lenvatinib Impurity CDP-082-SM2-IMP L
|
侖伐替尼雜質(zhì)CDP-082-SM2-imp L
|
|
|
CDP-065-imp R
|
利伐沙班雜質(zhì)H
|
1429334-00-8
|
|
Etoricoxib Impurity 15
|
3-二甲氨基-2-氯丙烯醛
|
73312-69-3
|
|
INDAPAMIDE RELATED COMPOUND A (50 MG) (4-CHLORO-N-(2-METHYL-INDOL-1-YL)-3-SULFAMOYLBEN-ZAMIDE) (AS)
|
吲達(dá)帕胺雜質(zhì)B 4-氯-N-（2-甲基-1-氫-吲哚基）-3-磺酰胺基苯甲酰胺
|
63968-75-2
|
|
(R)-9-[2-(DIETHYLPHOSPHONOMETHOXY)PROPYL] ADENINE
|
磷丙替諾福韋
|
180587-75-1
|
|
CHLOROSUCCINIC ACID
|
托法替布雜質(zhì)L2
|
16045-92-4
|
|
2-Methyl-2-thiazoline-4-carboxylic Acid Sodium Salt
|
4,5-二氫-2-甲基-4-噻唑羧酸鈉鹽
|
15058-19-2
|
|
phenyl hydrogen ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate
|
替諾福韋拉酚氨酯雜質(zhì)
|
379270-35-6
|
|
3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H-pyrido[1,2-a]pyrimidin-4-one (Paliperidone)
|
帕利哌酮雜質(zhì) PLPT-3
|
260273-82-3
|
|
Paliperidone Impurity 7
|
帕利哌酮雜質(zhì) PLPT-5
|
1415488-05-9
|
|
800027C-1
|
O-乙?；q降鈣素
|
|
|
2-bromo-4-fluoro-1,1'-biphenyl
|
氟比洛芬中間體雜質(zhì)
|
53591-98-3
|
|
800027F-1
|
鮭降鈣素雜質(zhì)A
|
|
|
CDP-082-SM2-imp H
|
Malonic acid hydrogen 1-isopropyl ester
|
56766-77-9
|
|
Degradation impurity 2 of salmon calcitonin injection
|
鮭降鈣素注射液降解雜質(zhì)2
|
|